TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Aarti Drugs Limited ( (IN:AARTIDRUGS) ) just unveiled an announcement.
Aarti Drugs Limited has announced the closure of its trading window starting October 1, 2025, in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015. This closure will remain in effect until 48 hours after the company declares its financial results for the quarter and half-year ending September 30, 2025. This measure is a standard regulatory practice aimed at preventing insider trading and ensuring transparency in financial disclosures, reflecting the company’s adherence to compliance norms.
More about Aarti Drugs Limited
Aarti Drugs Limited operates in the pharmaceutical industry, focusing on the production of active pharmaceutical ingredients (APIs), formulations, and specialty chemicals. The company is known for its extensive range of products catering to various therapeutic segments, positioning itself as a significant player in the pharmaceutical market.
Average Trading Volume: 34,347
Technical Sentiment Signal: Hold
Current Market Cap: 42.9B INR
Find detailed analytics on AARTIDRUGS stock on TipRanks’ Stock Analysis page.